{"description":"All grade 3 and above adverse events were reported","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":299,"description":"PSMA PET imaging: Patients will receive Ga-68 labeled PSMA-11 PET and then undergo PET/CT or PET/MRI approximately 55-70 minutes later.\n\nGa-68 labeled PSMA-11 PET: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":299,"seriousNumAffected":0,"seriousNumAtRisk":299,"title":"Ga-68 Labeled PSMA-11 PET"}],"frequencyThreshold":"5","timeFrame":"Up to 3 days"}